NEUROTRANSMITTER SYSTEM IMBALANCE IN CHRONIC DEPRESSION: THE ROLE OF SEROTONIN,DOPAMINE, ANDNOREPINEPHRINE.
Abstract
Chronic depression is a complex and multifactorial mental disorder characterized by persistent low mood, anhedonia, and cognitive dysfunction. One of the central mechanisms underlying this condition is the imbalance in key neurotransmitter systems, particularly serotonin, dopamine, and norepinephrine. Serotonin is primarily associated with mood regulation, emotional stability, and sleep patterns, and its deficiency is linked to increased anxiety and depressive symptoms. Dopamine plays a critical role in motivation, reward processing, and pleasure, and its dysregulation contributes to anhedonia and reduced motivation observed in chronic depression. Norepinephrine is involved in attention, arousal, and stress response, and its imbalance may lead to impaired concentration and fatigue. The interaction between these neurotransmitter systems creates a complex neurochemical network that influences the onset and progression of depressive disorders. Understanding these mechanisms is essential for improving pharmacological treatments and developing targeted therapeutic strategies for chronic depression.
References
1. Rakhmatova, M., Shakhanova, S., Nazarova, J., Azizova, F., Astanakulov, D., Akramov, G., &Mirametova, N. (2024). Brain tumor information retrieval system for brain tumor diagnosis. Health Leadership and Quality of Life, (3), 10.
2. RAKHMATOVA, M., SHAKHANOVA, S., NAZAROVA, J., AZIZOVA, F., ASTANAKULOV, D., AKRAMOV, G., & MIRAMETOVA, N. (2024). BRAIN TUMOR INFORMATION RETRIEVAL SYSTEM FOR BRAIN TUMOR DIAGNOSIS. HEALTH, 3.
3. Djuraev, N. N., Usmnova, M. B., Kozimjonova, I. F., Qayumjonov, O. Z., & Akramov, G. S. (2022). Social parameters characterizing personalities of patients with incomplete suicides. ACADEMICIA: An International Multidisciplinary Research Journal, 12(4), 377-381.
4. Soyibjono'g, A. G. A. THE EFFECTIVENESS OF COMBINING PSYCHOTHERAPY AND PHARMACOTHERAPY IN THE TREATMENT OF MENTAL DISORDERS.
5. Soyibjono'g, A. G. A. TYPOLOGY OF ANXIETY-PHOBIC DISORDERS.
6. Умарова, М., & Кодиржонов, Н. (2022). ТРОМБОЛИТИЧЕСКАЯ ТЕРАПИЯ В ЛЕЧЕНИИ ИШЕМИЧЕСКОГО ИНСУЛЬТА. Theoretical aspects in the formation of pedagogical sciences, 1(5), 218-220.
7. Умарова, М. (2021). ИНСОМНИА ВА МЕТАБОЛИК СИНДРОМНИНГ ЎЗАРО КОМОРБИДЛИГИ МУАММОНИНГ ДОЛЗАРБЛИГИ. Интернаука, (20-7), 29-30.
8. Умарова, М. (2021). МИГРЕН КАСАЛЛИГИ ВА УНИНГ ШОШИЛИНЧ ТЕРАПИЯСИНИ ТАКОМИЛЛАШТИРИШ. ИНТЕРНАУКА Учредители: Общество с ограниченной ответственностью" Интернаука, 93-94.
9. Умарова, М. (2021). ИНСУЛТДАН КЕЙИНГИ ТАЛВАСА СИНДРОМИ. Интернаука, (18-5), 46-48.
10. Музаффар, Ғ. (2023). БОҒЧА ЁШИДАГИ БОЛАЛАРДА БИЛИШ ЖАРАЁНЛАРИНИНГ РИВОЖЛАНИШИ. THEORY AND ANALYTICAL ASPECTS OF RECENT RESEARCH, 2(20), 26-29.
11. Muzaffar, G. (2023). Family Approach in PsychoCorrection of Disorders Identities of Patients with Schizophrenia. Eurasian Medical Research Periodical, 20, 243-247.
12. Dolimova, M. A., Agranovsky, M. L., Soliyev, D. M., & Gulomkodirov, M. M. (2022). The role of maintenance therapy in comparative effectiveness of the quality and structure of remissions in recurrent schizophrenia. Art of Medicine. International Medical Scientific Journal, 2(1).
13. G’ulomqodirov, M. M. (2024). REMITTIRLАSHGАN TIPDАGI KECHUVCHI SHIZOFRENIYANING UZOQ BOSQICHLАRI: TIPOLOGIYASI, KLINIKO-PSIXOPATOLOGIK XUSUSIYATLARI, PROGNOZI, PROFILAKTIKASI. IMRAS, 7(6), 383-386.
14. Maxmit o’g, G. U. M. (2025). NEVROTIK DEPRESSIYA: KLINIK KO ‘RINISHLAR, OLDINI OLISH VA DAVOLASH CHORALARI. O'ZBEKISTONDA FANLARARO INNOVATSIYALAR VA ILMIY TADQIQOTLAR JURNALI, 3(36), 220-222.
15. Muzaffar, G. U. (2025). SHIZOFRENIYA KASALLIGI HAMDA UNING KELIB CHIQISH SABABLARI. PEDAGOGICAL SCIENCES AND TEACHING METHODS, 4(41), 83-85.
16. Ibodullayevich, F. N., Al-Hussainy, A. F., H Tizkam, H., AbdulHussein, A. H., Salah, O. H., Edan, R. T., ... & Kamola Muminovna, A. (2024). Exploiting pH-Sensitive Polymer Micelles Nanoparticles for Paclitaxel Delivery and Tumor Suppression: Advanced Targeted Cancer Therapy. Journal of Nanostructures, 14(3), 945-952.
17. G‘ulomqodirov, M. M., & Muradimova, A. R. (2025). INSULTDAN KEYINGI DEPRESSIV SINDROMNI KLINIK KO’RINISHI. Журнал гуманитарных и естественных наук, (24), 39-45.
18. Maxmit o’g, G. U. M. (2025). ALZGEYMER KASALLIGI: KLINIK-XUSUSIYATLARI, DIAGNOS TIZIMI VA DAVOLASHGA YONDASHUVLAR. O'ZBEKISTONDA FANLARARO INNOVATSIYALAR VA ILMIY TADQIQOTLAR JURNALI, 4(40), 320-323.
22. Maxmit o’g, G. U. M. (2025). REAKTIV DEPRESSIYA: KLINIK KO ‘RINISHLAR, SABABLARI VA DAVOLASH. INNOVATIVE DEVELOPMENTS AND RESEARCH IN EDUCATION, 3(35), 205-207.
23. Maxmit o‘g, G. U. M. (2025). ISHEMIK INSULTDAN KEYINGI RUHIY BUZILISHLAR. O'ZBEKISTONDA FANLARARO INNOVATSIYALAR VA ILMIY TADQIQOTLAR JURNALI, 4(47), 414-417.
24. Maxmit o‘g, G. U. M. (2025). INSULTDAN KEYINGI DEPRESSIYA RIVOJLANISHIGA TA’SIR QILUVCHI ASOSIY XAVF OMILLARI VA ULARNING KLINIK-NEVROLOGIK KO ‘RINISHLARI. AMERICAN JOURNAL OF APPLIED MEDICAL SCIENCE, 3(11), 363-366.
